NEJM 3/26/09 – The NICE-SUGAR investigators published the latest of several trials that show no benefit to intensive glucose control (see meta-analysis). In fact, this study shows increased mortality from tight gylcemic control in the ICU.
Related Articles
This appears to be a well done study – over 6,000 subjects, multicenter, both medical and surgical patients, 90-day follow up. Withdrawals were slightly higher in the treatment arm (10 vs 7 percent) but intent-to-treat analysis was used. Insulin use was non-blinded.
So should the Intensive Glucose Control protocol be shelved next to blood-letting and COX-2 inhibitors?
This post first appeared on Consider The Evidence: Med/Peds Journal Roundup |, please read the originial post: here
